NL8601977A - Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. - Google Patents

Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. Download PDF

Info

Publication number
NL8601977A
NL8601977A NL8601977A NL8601977A NL8601977A NL 8601977 A NL8601977 A NL 8601977A NL 8601977 A NL8601977 A NL 8601977A NL 8601977 A NL8601977 A NL 8601977A NL 8601977 A NL8601977 A NL 8601977A
Authority
NL
Netherlands
Prior art keywords
pharmaceutical preparations
coenzyme
preparations according
alkaloids
flunarizine
Prior art date
Application number
NL8601977A
Other languages
English (en)
Dutch (nl)
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of NL8601977A publication Critical patent/NL8601977A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL8601977A 1985-08-02 1986-08-01 Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking. NL8601977A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH334485 1985-08-02
CH3344/85A CH670763A5 (de) 1985-08-02 1985-08-02

Publications (1)

Publication Number Publication Date
NL8601977A true NL8601977A (nl) 1987-03-02

Family

ID=4253937

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8601977A NL8601977A (nl) 1985-08-02 1986-08-01 Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking.

Country Status (9)

Country Link
US (1) US4778798A (de)
JP (1) JPS6253932A (de)
BE (2) BE905198A (de)
CH (1) CH670763A5 (de)
DE (1) DE3625877A1 (de)
FR (1) FR2591481B1 (de)
GB (1) GB2178314B (de)
IT (1) IT1197061B (de)
NL (1) NL8601977A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
FR2655854A1 (fr) * 1989-12-19 1991-06-21 Poissonnet Claude Medication nouvelle pour le traitement de surcharges lipidiques.
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US6133322A (en) * 1998-10-29 2000-10-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
DE19928528C2 (de) * 1999-06-22 2002-10-17 Heinz Kiefer Arzneimittel (Antiarteriosklerotikum) zur Vorbeugung und Linderung von Beschwerden bei arteriellen Durchblutungsstörungen auf der Grundlage von Ginkgobiloba
GB2368012A (en) * 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease
GB0209254D0 (en) * 2002-04-23 2002-06-05 Larkins Nicholas J Preparation for the relief of disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5938203B2 (ja) * 1976-04-26 1984-09-14 エーザイ株式会社 補酵素ｑを主成分とする脳循環障害治療剤
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
IT8621393A1 (it) 1988-02-01
IT8621393A0 (it) 1986-08-01
DE3625877A1 (de) 1987-02-05
FR2591481B1 (fr) 1992-05-29
BE905211A (nl) 1987-02-04
IT1197061B (it) 1988-11-25
GB8618249D0 (en) 1986-09-03
DE3625877C2 (de) 1992-04-02
BE905198A (nl) 1986-11-17
JPS6253932A (ja) 1987-03-09
CH670763A5 (de) 1989-07-14
FR2591481A1 (fr) 1987-06-19
GB2178314A (en) 1987-02-11
GB2178314B (en) 1990-02-21
US4778798A (en) 1988-10-18

Similar Documents

Publication Publication Date Title
NL8601977A (nl) Farmaceutische preparaten met vaatverwijdende en anti-anoxische werking.
US5283257A (en) Method of treating hyperproliferative vascular disease
JP2810599B2 (ja) 免疫炎症性疾患の治療用医薬組成物
JPH069390A (ja) 血管過剰増殖病治療用組成物
JPH0649651B2 (ja) 心筋虚血治療用医薬組成物
KR100331046B1 (ko) 쇼그렌증후군치료제
KR20010013690A (ko) 동맥 혈전증의 치료와 예방을 위한 조성물과 그 조성물단독 및/또는 혈소판 응집방지제와 결합한 인자 Ｘａ억제제의 사용법
US5081109A (en) Pharmaceutical composition and method for the therapy of peripheral arteriopathies
CA1036937A (en) Pharmaceutical heparinoidic factor-containing composition and therapeutic use thereof
WO1992003130A1 (en) Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
US5366960A (en) Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
US4298611A (en) Process for reducing blood pressure in animals
US4436732A (en) Medicated compound for treating diseases infected by virus of the herpes group
EP0444546B1 (de) Derivate des Hydantoins zur Verwendung als hypoglycemische und/oder hypolipidemische Wirkstoffe
US6455553B1 (en) Method for treating a demyelinating condition
KR100508623B1 (ko) 마크롤라이드 화합물의 신규한 용도
KR100194825B1 (ko) 말초 순환 개선제
EP0310259B1 (de) Eperisone als Hypotonikum
CA1172566A (en) Method for producing pharmaceutical preparation
JPS6379831A (ja) １，４−ジビドロピリジン誘導体およびアシル化１，２，３，４−テトラヒドロイソキノリン−３−カルボン酸を含有する医薬組成物
CA1285880C (en) Use of terguride as a geriatric agent
EP0115331B1 (de) Medikament gegen cerebrale Apoplexie
KR960014874B1 (ko) 요산 배출용 조성물
JPH02111722A (ja) 虚血性臓器障害予防・治療剤
US4847280A (en) Novel treatment

Legal Events

Date Code Title Description
BV The patent application has lapsed